Knight Therapeutics (KHTRF) Q2 2024 Earnings

9MayConfirmed
Aug 22
Nov 22
Q4 2023
Q2 2024
-0.17
-0.11
-0.04
0.02

Details

Expected EPS
0.009271792
Actual EPS
-0.029528
Surprise EPS
-0.04
Surprise Percent
+418.47%

Description

Knight Therapeutics (KHTRF) has reported earnings of -0.029528 per share for Q2 2024.

0 Comments

Share your thoughts